{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:28:17Z","timestamp":1788794897751,"version":"build-2803163510"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001787","name":"University of South Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.phrs.2021.105887","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T01:46:02Z","timestamp":1631756762000},"page":"105887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["A review of liquid biopsy as a tool to assess epigenetic, cfDNA and miRNA variability as methotrexate response predictors in patients with rheumatoid arthritis"],"prefix":"10.1016","volume":"173","author":[{"given":"Dala N.","family":"Daraghmeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5761-4746","authenticated-orcid":false,"given":"Catherine","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Wiese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.phrs.2021.105887_bib1","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/art.38306","article-title":"The epidemiology of rheumatoid arthritis in Ontario, Canada","volume":"66","author":"Widdifield","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"23","key":"10.1016\/j.phrs.2021.105887_bib2","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"New\u00a0Engl. J. Med."},{"key":"10.1016\/j.phrs.2021.105887_bib3","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2021.105887_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.39480","article-title":"American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105887_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13075-015-0671-9","volume":"17","author":"Smolen","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.phrs.2021.105887_bib6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/ard.2011.153551","article-title":"Predicting low disease activity and remission using early treatment response to antitumour necrosis factor therapy in patients with rheumatoid arthritis: exploratory analyses from the TEMPO trial","volume":"71","author":"Curtis","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.phrs.2021.105887_bib7","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3899\/jrheum.111171","article-title":"Timing and magnitude of initial change in disease activity score 28 predicts the likelihood of achieving low disease activity at 1 year in rheumatoid arthritis patients treated with certolizumab pegol: a post-hoc analysis of the RAPID 1 trial","volume":"39","author":"van der Heijde","year":"2012","journal-title":"J. Rheumatol."},{"issue":"10","key":"10.1016\/j.phrs.2021.105887_bib8","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1002\/art.22943","article-title":"Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients","volume":"56","author":"Aletaha","year":"2007","journal-title":"Arthritis Rheum.: Off. J. Am. Coll. Rheumatol."},{"key":"10.1016\/j.phrs.2021.105887_bib9","doi-asserted-by":"crossref","unstructured":"R.B. M\u00fcller, J. von Kempis, S.R. Haile, M.H. Schiff, Effectiveness, Tolerability, and Safety of Subcutaneous Methotrexate in Early Rheumatoid Arthritis: A Retrospective Analysis of Real-world Data from the St. Gallen cohort. Semin Arthritis Rheu, 2015, Elsevier.","DOI":"10.1016\/j.semarthrit.2015.02.009"},{"issue":"4","key":"10.1016\/j.phrs.2021.105887_bib10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00228-015-1819-x","article-title":"The role and utility of measuring red blood cell methotrexate polyglutamate concentrations in inflammatory arthropathies\u2014a systematic review","volume":"71","author":"Mohamed","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105887_bib11","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/jphp.12752","article-title":"Daily oral administration of low-dose methotrexate has greater antirheumatic effects in collagen-induced arthritis rats","volume":"69","author":"Koyama","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105887_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2016-000363","article-title":"Association of erythrocyte methotrexate-polyglutamate levels with the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a 76-week prospective study","volume":"3","author":"Takahashi","year":"2017","journal-title":"RMD Open"},{"issue":"8","key":"10.1016\/j.phrs.2021.105887_bib13","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.1424792112","article-title":"Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis","volume":"112","author":"Peres","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.phrs.2021.105887_bib14","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/annrheumdis-2018-213502","article-title":"Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate","volume":"77","author":"Smolen","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.phrs.2021.105887_bib15","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/art.40090","article-title":"Twenty\u2010year outcome and association between early treatment and mortality and disability in an inception cohort of patients with rheumatoid arthritis: results from the Norfolk Arthritis Register","volume":"69","author":"Gwinnutt","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"10086","key":"10.1016\/j.phrs.2021.105887_bib16","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","article-title":"Pathogenetic insights from the treatment of rheumatoid arthritis","volume":"389","author":"McInnes","year":"2017","journal-title":"Lancet"},{"issue":"10055","key":"10.1016\/j.phrs.2021.105887_bib17","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2021.105887_bib18","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.arth.2017.11.031","article-title":"Rheumatoid arthritis, disease modifying agents, and periprosthetic joint infection: what does a joint surgeon need to know?","volume":"33","author":"Yeganeh","year":"2018","journal-title":"J. Arthroplast."},{"issue":"2","key":"10.1016\/j.phrs.2021.105887_bib19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/CCO.0000000000000267","article-title":"The potential of liquid biopsies","volume":"28","author":"Buder","year":"2016","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.phrs.2021.105887_bib20","article-title":"Is prediction of clinical response to methotrexate in individual rheumatoid arthritis patients possible? A systematic literature review","author":"Roodenrijs","year":"2019","journal-title":"Jt. Bone Spine"},{"key":"10.1016\/j.phrs.2021.105887_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.intimp.2016.05.012","article-title":"The association between reduced folate carrier-1 gene 80G\/A polymorphism and methotrexate efficacy or methotrexate related-toxicity in rheumatoid arthritis: a meta-analysis","volume":"38","author":"Li","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.phrs.2021.105887_bib22","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00296-016-3523-2","article-title":"Association of the ATIC 347 C\/G polymorphism with responsiveness to and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis","volume":"36","author":"Lee","year":"2016","journal-title":"Rheumatol. Int."},{"issue":"2","key":"10.1016\/j.phrs.2021.105887_bib23","first-page":"137","article-title":"MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms","volume":"13","author":"Owen","year":"2013","journal-title":"Pharm. J."},{"issue":"2","key":"10.1016\/j.phrs.2021.105887_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/11531070-000000000-00000","article-title":"Associations between the C677T and A1298C polymorphisms of MTHFR and the efficacy and toxicity of methotrexate in rheumatoid arthritis","volume":"30","author":"Lee","year":"2010","journal-title":"Clin. Drug Investig."},{"issue":"12","key":"10.1016\/j.phrs.2021.105887_bib25","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1634\/theoncologist.2015-0164","article-title":"Preventing and managing toxicities of high-dose methotrexate","volume":"21","author":"Howard","year":"2016","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.phrs.2021.105887_bib26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s40262-015-0316-9","article-title":"Pharmacology and optimization of thiopurines and methotrexate in inflammatory bowel disease","volume":"55","author":"Coskun","year":"2016","journal-title":"Clin. Pharmacokinet."},{"issue":"12","key":"10.1016\/j.phrs.2021.105887_bib27","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2016.175","article-title":"Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers","volume":"12","author":"Brown","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.phrs.2021.105887_bib28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2147\/OARRR.S131668","article-title":"Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis","volume":"9","author":"Bello","year":"2017","journal-title":"Open Access Rheumatol.: Res. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2021.105887_bib29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13075-019-1936-5","article-title":"Higher baseline global leukocyte DNA methylation is associated with MTX non-response in early RA patients","volume":"21","author":"Gosselt","year":"2019","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.phrs.2021.105887_bib30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrrheum.2014.16","article-title":"Genetic and epigenetic predictors of responsiveness to treatment in RA","volume":"10","author":"Plant","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.phrs.2021.105887_bib31","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/1744666X.2018.1465409","article-title":"Prediction of response to methotrexate in rheumatoid arthritis","volume":"14","author":"Ling","year":"2018","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2021.105887_bib32","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/1759720X15598307","article-title":"Towards an understanding of the role of DNA methylation in rheumatoid arthritis: therapeutic and diagnostic implications","volume":"7","author":"Cribbs","year":"2015","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"issue":"6648","key":"10.1016\/j.phrs.2021.105887_bib33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/38444","article-title":"Crystal structure of the nucleosome core particle at 2.8 A resolution","volume":"389","author":"Luger","year":"1997","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.phrs.2021.105887_bib34","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.phrs.2021.105887_bib35","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/art.33382","article-title":"Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3\u2013selective inhibitor reduces interleukin\u20106 production by peripheral blood mononuclear cells from rheumatoid arthritis patients","volume":"64","author":"Gillespie","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.phrs.2021.105887_bib36","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.phrs.2021.105887_bib37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2741\/1506","article-title":"Citrullinated proteins in rheumatoid arthritis","volume":"10","author":"Yamada","year":"2005","journal-title":"Front. Biosci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105887_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms1676","article-title":"Regulation of histone modification and chromatin structure by the p53\u2013PADI4 pathway","volume":"3","author":"Tanikawa","year":"2012","journal-title":"Nat. Commun."},{"issue":"209","key":"10.1016\/j.phrs.2021.105887_bib39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1126\/scitranslmed.3006869","article-title":"Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis","volume":"5","author":"Romero","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phrs.2021.105887_bib40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.clim.2018.03.011","article-title":"Epigenetics as biomarkers in autoimmune diseases","volume":"196","author":"Wu","year":"2018","journal-title":"Clin. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2021.105887_bib41","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.cell.2012.02.045","article-title":"Regulated noise in the epigenetic landscape of development and disease","volume":"148","author":"Pujadas","year":"2012","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.phrs.2021.105887_bib42","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2217\/pgs-2016-0195","article-title":"DNA methylation as a marker of response in rheumatoid arthritis","volume":"18","author":"Nair","year":"2017","journal-title":"Pharmacogenomics"},{"issue":"4","key":"10.1016\/j.phrs.2021.105887_bib43","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ajhg.2011.03.003","article-title":"Tobacco-smoking-related differential DNA methylation: 27K discovery and replication","volume":"88","author":"Breitling","year":"2011","journal-title":"Am. J. Hum. Genet."},{"issue":"12","key":"10.1016\/j.phrs.2021.105887_bib44","doi-asserted-by":"crossref","first-page":"22279","DOI":"10.3390\/ijms151222279","article-title":"Smoking and rheumatoid arthritis","volume":"15","author":"Chang","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.phrs.2021.105887_bib45","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1002\/art.25018","article-title":"DNA hypomethylation in rheumatoid arthritis synovial fibroblasts","volume":"60","author":"Karouzakis","year":"2009","journal-title":"Arthritis Rheum.: Off. J. Am. Coll. Rheumatol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105887_bib46","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.bbrc.2014.01.195","article-title":"Aberrant histone acetylation contributes to elevated interleukin-6 production in rheumatoid arthritis synovial fibroblasts","volume":"444","author":"Wada","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.phrs.2021.105887_bib47","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/nbt.2487","article-title":"Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis","volume":"31","author":"Liu","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.phrs.2021.105887_bib48","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ng.1076","article-title":"Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis","volume":"44","author":"Raychaudhuri","year":"2012","journal-title":"Nat. Genet."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2021.105887_bib49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s13317-015-0066-6","article-title":"Decreased serum cell-free DNA levels in rheumatoid arthritis","volume":"6","author":"Dunaeva","year":"2015","journal-title":"Autoimmun. Highlights"},{"issue":"1","key":"10.1016\/j.phrs.2021.105887_bib50","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13075-017-1276-2","article-title":"DNA methylation mediates genotype and smoking interaction in the development of anti-citrullinated peptide antibody-positive rheumatoid arthritis","volume":"19","author":"Meng","year":"2017","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2021.105887_bib51","first-page":"281","article-title":"Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness","volume":"24","author":"Del Amo","year":"2006","journal-title":"Clin. Exp. Rheumatol."},{"issue":"12","key":"10.1016\/j.phrs.2021.105887_bib52","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/ard.2004.033571","article-title":"Longitudinal analysis of citrullinated protein\/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression","volume":"64","author":"R\u00f6nnelid","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.phrs.2021.105887_bib53","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/ard.2009.126821","article-title":"A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis","volume":"70","author":"Padyukov","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2021.105887_bib54","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination","volume":"54","author":"Klareskog","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.phrs.2021.105887_bib55","first-page":"165","article-title":"DNA hypomethylation in inflammatory arthritis: reversal with methotrexate","volume":"128","author":"Kim","year":"1996","journal-title":"Transl. Res."},{"issue":"1","key":"10.1016\/j.phrs.2021.105887_bib56","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s13075-015-0748-5","article-title":"Assessment of global DNA methylation in peripheral blood cell subpopulations of early rheumatoid arthritis before and after methotrexate","volume":"17","author":"de Andres","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.phrs.2021.105887_bib57","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/rheumatology\/kez411","article-title":"Differential DNA methylation correlates with response to methotrexate in rheumatoid arthritis","volume":"59","author":"Nair","year":"2020","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.phrs.2021.105887_bib58","doi-asserted-by":"crossref","first-page":"66468","DOI":"10.1371\/journal.pone.0066468","article-title":"Genome-wide gene expression profiling revealed a critical role for GATA3 in the maintenance of the Th2 cell identity","volume":"8","author":"Sasaki","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.phrs.2021.105887_bib59","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.4049\/jimmunol.1502044","article-title":"RBP-J\u2013regulated miR-182 promotes TNF-\u03b1\u2013induced osteoclastogenesis","volume":"196","author":"Miller","year":"2016","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105887_bib60","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2217\/epi-2016-0042","article-title":"DNA methylation at diagnosis is associated with response to disease-modifying drugs in early rheumatoid arthritis","volume":"9","author":"Glossop","year":"2017","journal-title":"Epigenomics"},{"issue":"1","key":"10.1016\/j.phrs.2021.105887_bib61","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.it.2011.09.007","article-title":"Butyrophilins: an emerging family of immune regulators","volume":"33","author":"Abeler-D\u00f6rner","year":"2012","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2021.105887_bib62","article-title":"Epigenome wide association study of response to methotrexate in early rheumatoid arthritis patients","volume":"16","author":"Gosselt","year":"2021","journal-title":"PLoS\u00a0One"},{"issue":"4","key":"10.1016\/j.phrs.2021.105887_bib63","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/annrheumdis-2015-207942","article-title":"Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial","volume":"75","author":"Sokolove","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.phrs.2021.105887_bib64","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/ard.2010.139212","article-title":"Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial","volume":"70","author":"Saevarsdottir","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.phrs.2021.105887_bib65","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1136\/annrheumdis-2013-203566","article-title":"An immunological biomarker to predict MTX response in early RA","volume":"73","author":"Ponchel","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2021.105887_bib66","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12891-015-0587-1","article-title":"Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis","volume":"16","author":"Ally","year":"2015","journal-title":"BMC Musculoskelet. Disord."},{"issue":"9","key":"10.1016\/j.phrs.2021.105887_bib67","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1136\/annrheumdis-2011-200736","article-title":"Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study)","volume":"71","author":"Wevers-de Boer","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.phrs.2021.105887_bib68","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.bbrc.2009.12.072","article-title":"Inhibition of histone deacetylase activity is a novel function of the antifolate drug methotrexate","volume":"391","author":"Yang","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.phrs.2021.105887_bib69","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ejr.2016.06.005","article-title":"Levels of plasma cell-free DNA and its correlation with disease activity in rheumatoid arthritis and systemic lupus erythematosus patients","volume":"38","author":"Abdelal","year":"2016","journal-title":"Egypt. Rheumatol."},{"issue":"6","key":"10.1016\/j.phrs.2021.105887_bib70","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/1756-185X.12959","article-title":"Circulating cell free DNA: a marker to predict the therapeutic response for biological DMARDs in rheumatoid arthritis","volume":"20","author":"Hashimoto","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2021.105887_bib71","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1749-6632.2000.tb06608.x","article-title":"The origin and mechanism of circulating DNA","volume":"906","author":"Stroun","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.phrs.2021.105887_bib72","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00296-018-4055-8","article-title":"Anti-cytokine therapy and plasma DNA in patients with rheumatoid arthritis","volume":"38","author":"Laukov\u00e1","year":"2018","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.phrs.2021.105887_bib73","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/782123","article-title":"GC-rich extracellular DNA induces oxidative stress, double-strand DNA breaks, and DNA damage response in human adipose-derived mesenchymal stem cells","volume":"2015","author":"Kostyuk","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"9","key":"10.1016\/j.phrs.2021.105887_bib74","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1373\/clinchem.2006.084509","article-title":"Increased concentrations of antibody-bound circulatory cell-free DNA in rheumatoid arthritis","volume":"53","author":"Zhong","year":"2007","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2021.105887_bib75","first-page":"139","article-title":"Free DNA in the serum of rheumatoid arthritis patients","volume":"4","author":"Leon","year":"1977","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105887_bib76","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1158\/1055-9965.251.14.1","article-title":"Comparison of archival plasma and formalin-fixed paraffin-embedded tissue for genotyping in hepatocellular carcinoma","volume":"14","author":"Sj\u00f6holm","year":"2005","journal-title":"Cancer Epidemiol.\u00a0Prev. Biomark."},{"issue":"10","key":"10.1016\/j.phrs.2021.105887_bib77","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1517\/13543784.16.10.1601","article-title":"The anti-inflammatory effect of A3 adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis","volume":"16","author":"Bar-Yehuda","year":"2007","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"3\u20134","key":"10.1016\/j.phrs.2021.105887_bib78","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaut.2009.02.012","article-title":"MicroRNA in autoimmunity and autoimmune diseases","volume":"32","author":"Pauley","year":"2009","journal-title":"J. Autoimmun."},{"issue":"12","key":"10.1016\/j.phrs.2021.105887_bib79","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.autrev.2016.09.003","article-title":"The role of microRNAs in the pathogenesis of autoimmune diseases","volume":"15","author":"Chen","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"8","key":"10.1016\/j.phrs.2021.105887_bib80","doi-asserted-by":"crossref","first-page":"824","DOI":"10.7150\/ijms.8358","article-title":"Frequent co-expression of miRNA-5p and-3p species and cross-targeting in induced pluripotent stem cells","volume":"11","author":"Huang","year":"2014","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105887_bib81","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12929-014-0095-x","article-title":"MicroRNA-5p and-3p co-expression and cross-targeting in colon cancer cells","volume":"21","author":"Choo","year":"2014","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105887_bib82","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s12291-017-0652-7","article-title":"Pre-micro RNA-499 gene polymorphism rs3746444 T\/C is associated with susceptibility to rheumatoid arthritis in Egyptian population","volume":"33","author":"Fattah","year":"2018","journal-title":"Indian J. Clin. Biochem."},{"issue":"11","key":"10.1016\/j.phrs.2021.105887_bib83","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.autrev.2015.07.005","article-title":"MicroRNAs in rheumatoid arthritis: altered expression and diagnostic potential","volume":"14","author":"Churov","year":"2015","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2021.105887_bib84","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s13075-016-1178-8","article-title":"Extracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritis","volume":"18","author":"Withrow","year":"2016","journal-title":"Arthritis Res. Ther."},{"issue":"4","key":"10.1016\/j.phrs.2021.105887_bib85","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/art.23386","article-title":"Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis","volume":"58","author":"Stanczyk","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.phrs.2021.105887_bib86","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/annrheumdis-2013-204377","article-title":"Decreased expression of miR-146a and miR-155 contributes to an abnormal Treg phenotype in patients with rheumatoid arthritis","volume":"74","author":"Zhou","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.phrs.2021.105887_bib87","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/ar2493","article-title":"Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients","volume":"10","author":"Pauley","year":"2008","journal-title":"Arthritis Res. Ther."},{"issue":"10","key":"10.1016\/j.phrs.2021.105887_bib88","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1136\/annrheumdis-2012-202815","article-title":"Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis","volume":"73","author":"Filkov\u00e1","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.phrs.2021.105887_bib89","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s10067-018-4380-z","article-title":"MicroRNA-132, miR-146a, and miR-155 as potential biomarkers of methotrexate response in patients with rheumatoid arthritis","volume":"38","author":"Singh","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.phrs.2021.105887_bib90","article-title":"Plasma MicroRNA profiles in patients with early rheumatoid arthritis responding to adalimumab plus methotrexate vs methotrexate alone: a placebo-controlled clinical trial","author":"Sode","year":"2017","journal-title":"J. Rheumatol."},{"issue":"12","key":"10.1016\/j.phrs.2021.105887_bib91","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1074\/jbc.M117.775684","article-title":"A-to-I RNA editing up-regulates human dihydrofolate reductase in breast cancer","volume":"292","author":"Nakano","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"33","key":"10.1016\/j.phrs.2021.105887_bib92","doi-asserted-by":"crossref","first-page":"13513","DOI":"10.1073\/pnas.0706217104","article-title":"A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance","volume":"104","author":"Mishra","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.phrs.2021.105887_bib93","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10753-016-0304-8","article-title":"Correlation between the expression of microRNA-301a-3p and the proportion of Th17cells in patients with rheumatoid arthritis","volume":"39","author":"Tang","year":"2016","journal-title":"Inflammation"},{"issue":"20","key":"10.1016\/j.phrs.2021.105887_bib94","doi-asserted-by":"crossref","first-page":"7865","DOI":"10.1073\/pnas.1200081109","article-title":"MicroRNAs miR-125a and miR-125b constitutively activate the NF-\u03baB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20)","volume":"109","author":"Kim","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.phrs.2021.105887_bib95","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.yexmp.2015.12.015","article-title":"microRNA-126 targeting PIK3R2 promotes rheumatoid arthritis synovial fibro-blasts proliferation and resistance to apoptosis by regulating PI3K\/AKT pathway","volume":"100","author":"Gao","year":"2016","journal-title":"Exp. Mol. Pathol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105887_bib96","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3109\/s10165-012-0710-1","article-title":"Overexpression of microRNA-223 in rheumatoid arthritis synovium controls osteoclast differentiation","volume":"23","author":"Shibuya","year":"2013","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.phrs.2021.105887_bib97","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cca.2017.09.001","article-title":"Folate and microRNA: bidirectional interactions","volume":"474","author":"Beckett","year":"2017","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.phrs.2021.105887_bib98","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/art.38142","article-title":"A novel p53\/microRNA\u201022\/Cyr61 axis in synovial cells regulates inflammation in rheumatoid arthritis","volume":"66","author":"Lin","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.phrs.2021.105887_bib99","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/art.30115","article-title":"Altered expression of microRNA\u2010203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation","volume":"63","author":"Stanczyk","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.phrs.2021.105887_bib100","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3892\/or.2014.3646","article-title":"miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer","volume":"33","author":"Li","year":"2015","journal-title":"Oncol. Rep."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821004710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821004710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T01:49:04Z","timestamp":1734400144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661821004710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":100,"alternative-id":["S1043661821004710"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105887","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of liquid biopsy as a tool to assess epigenetic, cfDNA and miRNA variability as methotrexate response predictors in patients with rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105887","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105887"}}